Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action

Remdesivir (RDV) is a direct-acting antiviral agent that is used to treat patients with severe coronavirus disease 2019 (COVID-19). RDV targets the viral RNA-dependent RNA polymerase (RdRp) of severe acute respiratory syndrome coronavirus 2 (SARS–CoV-2). We have previously shown that incorporation o...

Descripción completa

Detalles Bibliográficos
Autores principales: Tchesnokov, Egor P., Gordon, Calvin J., Woolner, Emma, Kocinkova, Dana, Perry, Jason K., Feng, Joy Y., Porter, Danielle P., Götte, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2020
Materias:
Enzymology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7681019/
https://www.ncbi.nlm.nih.gov/pubmed/32967965
http://dx.doi.org/10.1074/jbc.AC120.015720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7681019/
https://www.ncbi.nlm.nih.gov/pubmed/32967965
http://dx.doi.org/10.1074/jbc.AC120.015720

Ejemplares similares